A supratherapeutic dose of the Janus kinase inhibitor tasocitinib (CP-690,550) does not prolong QTc interval in healthy participants. (Q51528930)
Jump to navigation
Jump to search
scientific article published on 8 December 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A supratherapeutic dose of the Janus kinase inhibitor tasocitinib (CP-690,550) does not prolong QTc interval in healthy participants. |
scientific article published on 8 December 2010 |
Statements
A supratherapeutic dose of the Janus kinase inhibitor tasocitinib (CP-690,550) does not prolong QTc interval in healthy participants. (English)
1 reference
Sriram Krishnaswami
1 reference
Elizabeth Kudlacz
1 reference
Rong Wang
1 reference
Gary Chan
1 reference
8 December 2010
1 reference
51
1 reference
9
1 reference
1256-1263
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference